Click for best price
Irritable Bowel Syndrome Treatment Drug Market Size, Share 2024
The global Irritable Bowel Syndrome Treatment Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Antibiotics Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Irritable Bowel Syndrome Treatment Drug include Abbvie Inc., Bristol Myers Squibb, Roche, Johnson & Johnson, Pfizer Inc., Prometheus Laboratories Inc. (Nestle), Bausch Health, Takeda Pharmaceutical Ltd and Biogen, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Irritable bowel syndrome (IBS) is?a common condition that affects the digestive system. It causes symptoms like stomach cramps, bloating, diarrhoea and constipation. These tend to come and go over time, and can last for days, weeks or months at a time. It's usually a lifelong problem.
This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome Treatment Drug. This report contains market size and forecasts of Irritable Bowel Syndrome Treatment Drug in global, including the following market information:
Global Irritable Bowel Syndrome Treatment Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Irritable Bowel Syndrome Treatment Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Irritable Bowel Syndrome Treatment Drug Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Irritable Bowel Syndrome Treatment Drug Market Segment Percentages, by Type, 2023 (%)
Antibiotics
Amino Salicylates
Corticosteroids
Immunomodulators
Others
Global Irritable Bowel Syndrome Treatment Drug Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Irritable Bowel Syndrome Treatment Drug Market Segment Percentages, by Application, 2023 (%)
Hospitals
Specialty Clinics
Other
Global Irritable Bowel Syndrome Treatment Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Irritable Bowel Syndrome Treatment Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Irritable Bowel Syndrome Treatment Drug revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Irritable Bowel Syndrome Treatment Drug revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie Inc.
Bristol Myers Squibb
Roche
Johnson & Johnson
Pfizer Inc.
Prometheus Laboratories Inc. (Nestle)
Bausch Health
Takeda Pharmaceutical Ltd
Biogen
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Irritable Bowel Syndrome Treatment Drug, market overview.
Chapter 2: Global Irritable Bowel Syndrome Treatment Drug market size in revenue.
Chapter 3: Detailed analysis of Irritable Bowel Syndrome Treatment Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Irritable Bowel Syndrome Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Irritable Bowel Syndrome Treatment Drug Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Irritable Bowel Syndrome Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Irritable Bowel Syndrome Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Irritable Bowel Syndrome Treatment Drug Overall Market Size
2.1 Global Irritable Bowel Syndrome Treatment Drug Market Size: 2023 VS 2030
2.2 Global Irritable Bowel Syndrome Treatment Drug Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Irritable Bowel Syndrome Treatment Drug Players in Global Market
3.2 Top Global Irritable Bowel Syndrome Treatment Drug Companies Ranked by Revenue
3.3 Global Irritable Bowel Syndrome Treatment Drug Revenue by Companies
3.4 Top 3 and Top 5 Irritable Bowel Syndrome Treatment Drug Companies in Global Market, by Revenue in 2023
3.5 Global Companies Irritable Bowel Syndrome Treatment Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Irritable Bowel Syndrome Treatment Drug Players in Global Market
3.6.1 List of Global Tier 1 Irritable Bowel Syndrome Treatment Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome Treatment Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Irritable Bowel Syndrome Treatment Drug Market Size Markets, 2023 & 2030
4.1.2 Antibiotics
4.1.3 Amino Salicylates
4.1.4 Corticosteroids
4.1.5 Immunomodulators
4.1.6 Others
4.2 By Type - Global Irritable Bowel Syndrome Treatment Drug Revenue & Forecasts
4.2.1 By Type - Global Irritable Bowel Syndrome Treatment Drug Revenue, 2019-2024
4.2.2 By Type - Global Irritable Bowel Syndrome Treatment Drug Revenue, 2025-2030
4.2.3 By Type - Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Irritable Bowel Syndrome Treatment Drug Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Other
5.2 By Application - Global Irritable Bowel Syndrome Treatment Drug Revenue & Forecasts
5.2.1 By Application - Global Irritable Bowel Syndrome Treatment Drug Revenue, 2019-2024
5.2.2 By Application - Global Irritable Bowel Syndrome Treatment Drug Revenue, 2025-2030
5.2.3 By Application - Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Irritable Bowel Syndrome Treatment Drug Market Size, 2023 & 2030
6.2 By Region - Global Irritable Bowel Syndrome Treatment Drug Revenue & Forecasts
6.2.1 By Region - Global Irritable Bowel Syndrome Treatment Drug Revenue, 2019-2024
6.2.2 By Region - Global Irritable Bowel Syndrome Treatment Drug Revenue, 2025-2030
6.2.3 By Region - Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Irritable Bowel Syndrome Treatment Drug Revenue, 2019-2030
6.3.2 US Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.3.3 Canada Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.3.4 Mexico Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Irritable Bowel Syndrome Treatment Drug Revenue, 2019-2030
6.4.2 Germany Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.4.3 France Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.4.4 U.K. Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.4.5 Italy Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.4.6 Russia Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.4.7 Nordic Countries Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.4.8 Benelux Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Irritable Bowel Syndrome Treatment Drug Revenue, 2019-2030
6.5.2 China Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.5.3 Japan Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.5.4 South Korea Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.5.5 Southeast Asia Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.5.6 India Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Irritable Bowel Syndrome Treatment Drug Revenue, 2019-2030
6.6.2 Brazil Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.6.3 Argentina Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Irritable Bowel Syndrome Treatment Drug Revenue, 2019-2030
6.7.2 Turkey Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.7.3 Israel Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.7.4 Saudi Arabia Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
6.7.5 UAE Irritable Bowel Syndrome Treatment Drug Market Size, 2019-2030
7 Irritable Bowel Syndrome Treatment Drug Companies Profiles
7.1 Abbvie Inc.
7.1.1 Abbvie Inc. Company Summary
7.1.2 Abbvie Inc. Business Overview
7.1.3 Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.1.4 Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2019-2024)
7.1.5 Abbvie Inc. Key News & Latest Developments
7.2 Bristol Myers Squibb
7.2.1 Bristol Myers Squibb Company Summary
7.2.2 Bristol Myers Squibb Business Overview
7.2.3 Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.2.4 Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2019-2024)
7.2.5 Bristol Myers Squibb Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.3.4 Roche Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2019-2024)
7.3.5 Roche Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.4.4 Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2019-2024)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Company Summary
7.5.2 Pfizer Inc. Business Overview
7.5.3 Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.5.4 Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2019-2024)
7.5.5 Pfizer Inc. Key News & Latest Developments
7.6 Prometheus Laboratories Inc. (Nestle)
7.6.1 Prometheus Laboratories Inc. (Nestle) Company Summary
7.6.2 Prometheus Laboratories Inc. (Nestle) Business Overview
7.6.3 Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.6.4 Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2019-2024)
7.6.5 Prometheus Laboratories Inc. (Nestle) Key News & Latest Developments
7.7 Bausch Health
7.7.1 Bausch Health Company Summary
7.7.2 Bausch Health Business Overview
7.7.3 Bausch Health Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.7.4 Bausch Health Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2019-2024)
7.7.5 Bausch Health Key News & Latest Developments
7.8 Takeda Pharmaceutical Ltd
7.8.1 Takeda Pharmaceutical Ltd Company Summary
7.8.2 Takeda Pharmaceutical Ltd Business Overview
7.8.3 Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.8.4 Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2019-2024)
7.8.5 Takeda Pharmaceutical Ltd Key News & Latest Developments
7.9 Biogen
7.9.1 Biogen Company Summary
7.9.2 Biogen Business Overview
7.9.3 Biogen Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.9.4 Biogen Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2019-2024)
7.9.5 Biogen Key News & Latest Developments
7.10 AstraZeneca
7.10.1 AstraZeneca Company Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Irritable Bowel Syndrome Treatment Drug Major Product Offerings
7.10.4 AstraZeneca Irritable Bowel Syndrome Treatment Drug Revenue in Global Market (2019-2024)
7.10.5 AstraZeneca Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Irritable Bowel Syndrome Treatment Drug Market Opportunities & Trends in Global Market
Table 2. Irritable Bowel Syndrome Treatment Drug Market Drivers in Global Market
Table 3. Irritable Bowel Syndrome Treatment Drug Market Restraints in Global Market
Table 4. Key Players of Irritable Bowel Syndrome Treatment Drug in Global Market
Table 5. Top Irritable Bowel Syndrome Treatment Drug Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Irritable Bowel Syndrome Treatment Drug Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Irritable Bowel Syndrome Treatment Drug Revenue Share by Companies, 2019-2024
Table 8. Global Companies Irritable Bowel Syndrome Treatment Drug Product Type
Table 9. List of Global Tier 1 Irritable Bowel Syndrome Treatment Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome Treatment Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Irritable Bowel Syndrome Treatment Drug Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Irritable Bowel Syndrome Treatment Drug Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Irritable Bowel Syndrome Treatment Drug Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Irritable Bowel Syndrome Treatment Drug Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 30. Abbvie Inc. Company Summary
Table 31. Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 32. Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 33. Abbvie Inc. Key News & Latest Developments
Table 34. Bristol Myers Squibb Company Summary
Table 35. Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 36. Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 37. Bristol Myers Squibb Key News & Latest Developments
Table 38. Roche Company Summary
Table 39. Roche Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 40. Roche Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 41. Roche Key News & Latest Developments
Table 42. Johnson & Johnson Company Summary
Table 43. Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 44. Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. Pfizer Inc. Company Summary
Table 47. Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 48. Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 49. Pfizer Inc. Key News & Latest Developments
Table 50. Prometheus Laboratories Inc. (Nestle) Company Summary
Table 51. Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 52. Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 53. Prometheus Laboratories Inc. (Nestle) Key News & Latest Developments
Table 54. Bausch Health Company Summary
Table 55. Bausch Health Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 56. Bausch Health Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 57. Bausch Health Key News & Latest Developments
Table 58. Takeda Pharmaceutical Ltd Company Summary
Table 59. Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 60. Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 61. Takeda Pharmaceutical Ltd Key News & Latest Developments
Table 62. Biogen Company Summary
Table 63. Biogen Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 64. Biogen Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 65. Biogen Key News & Latest Developments
Table 66. AstraZeneca Company Summary
Table 67. AstraZeneca Irritable Bowel Syndrome Treatment Drug Product Offerings
Table 68. AstraZeneca Irritable Bowel Syndrome Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 69. AstraZeneca Key News & Latest Developments
List of Figures
Figure 1. Irritable Bowel Syndrome Treatment Drug Segment by Type in 2023
Figure 2. Irritable Bowel Syndrome Treatment Drug Segment by Application in 2023
Figure 3. Global Irritable Bowel Syndrome Treatment Drug Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Irritable Bowel Syndrome Treatment Drug Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Irritable Bowel Syndrome Treatment Drug Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Irritable Bowel Syndrome Treatment Drug Revenue in 2023
Figure 8. By Type - Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2019-2030
Figure 9. By Application - Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2019-2030
Figure 10. By Type - Global Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2019-2030
Figure 12. By Application - Global Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2019-2030
Figure 14. By Region - Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2019-2030
Figure 15. By Country - North America Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2019-2030
Figure 16. US Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2019-2030
Figure 20. Germany Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 21. France Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2019-2030
Figure 28. China Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 32. India Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2019-2030
Figure 34. Brazil Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Irritable Bowel Syndrome Treatment Drug Revenue Market Share, 2019-2030
Figure 37. Turkey Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Irritable Bowel Syndrome Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 41. Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Roche Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Bausch Health Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Biogen Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. AstraZeneca Irritable Bowel Syndrome Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
